Trial Profile
Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 04 Apr 2019 Status changed from recruiting to completed.
- 20 Aug 2018 Planned End Date changed from 1 Jul 2018 to 1 Dec 2018.
- 20 Aug 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Dec 2018.